Premium
Systemic effects of two nasally administered glucocorticosteroids
Author(s) -
Wihl J.Å.,
Andersson K.E.,
Johansson S.Å.
Publication year - 1997
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/j.1398-9995.1997.tb01040.x
Subject(s) - budesonide , medicine , urine , plasma concentration , anesthesia , glucocorticoid , hydrocortisone , pharmacology , corticosteroid
Two topical corticosteroids, budesonide (BUD) and beclomethasone dipropionate (BDP), both administered as suspensions in water, were investigated in healthy volunteers regarding influence on cortisol in plasma and urine (U‐cortisol) after nasal application. In the first study, single doses of 200, 400, and 800 μg of BDP and BUD were given at 10:00 pm. In the second study, 100, 200, and 400 μg were given mornings and evenings for 4 days. In the single‐dose study, none of the drugs or doses showed any significant influence on cortisol in plasma. However, U‐cortisol decreased significantly after BUD 400 and 800 μg. In the multidose study, U‐cortisol values were significantly reduced after all doses of BUD and the highest dose of BDP. The compounds tested showed different ability to cause measurable systemic effects after nasal application. The clinical implication is that the prescriber, when choosing a compound, should take the application site into consideration and should also be encouraged to find the lowest effective dose.